Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort study

Cancer Causes and Control

Volumn 25, Issue 8, 2014, Pages 1075-1080

  Taghizadeh, N ^a   Vonk, J M ^a   Boezen, H M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cancer mortality; Cholesterol; Serum uric acid; Triglyceride

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BODY MASS; CANCER MORTALITY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COLORECTAL CANCER; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; COLORECTAL TUMOR; EPIDEMIOLOGY; LUNG TUMOR; MORTALITY; NEOPLASM; NETHERLANDS; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; URINE;

ADULT; COHORT STUDIES; COLORECTAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; URIC ACID;

EID: 84904551644     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0408-0     Document Type: Article

References (28)

1. Soltani Z, Rasheed K, Kapusta DR et al (2013) Potential role of uric acid in metabolic syndrome, hypertension, kidney Injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep 15:175-181
2. Zhao G, Huang L, Song M et al (2013) Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis 231:61-68
3. Kuo CF, See LC, Yu KH et al (2013) Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford) 52:127-134
4. Jee SH, Lee SY, Kim MT (2004) Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prev Rehabil 11:185-191 (Pubitemid 38870064)
5. Fini MA, Elias A, Johnson RJ et al (2012) Contribution of uric acid to cancer risk, recurrence, and mortality. Clin Transl Med 1:1-16
6. Strasak AM, Rapp K, Hilbe W et al (2007) Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer Causes Control 18:1021-1029 (Pubitemid 47237964)
7. Petersson B, Trell E (1983) Raised serum urate concentration as risk factor for premature mortality in middle aged men: relation to death from cancer. Br Med J (Clin Res Ed) 287:7-9 (Pubitemid 13062819)
8. Hille R (2005) Molybdenum-containing hydroxylases. Arch Biochem Biophys 433:107-116
9. Wu L, Wu JT (2008) Serum uric acid is a marker of inflammation and a marker predicting the risk of developing CVD, stroke, renal failure and cancer. J Biomed Lab Sci 20:1-2
10. Ames BN, Cathcart R, Schwiers E et al (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78:6858-6862 (Pubitemid 12216861)
11. Kanbay M, Segal M, Afsar B et al (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759-766
12. Hospers JJ, Schouten JP, Weiss ST et al (2000) Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology 11:261-268 (Pubitemid 30228192)
13. van der Lende R, Kok TJ, Reig RP et al (1981) Decreases in VC and FEV1 with time: indicators for effects of smoking and air pollution. Bull Eur Physiopathol Respir 17:775-792 (Pubitemid 11022170)
14. Patel CP (1968) Semimicro method for determination of serum uric acid using EDTA-hydrazine. Clin Chem 14:764-775
15. Huang YC, Kao JT, Tsai KS (1997) Evaluation of two homogeneous methods for measuring high-density lipoprotein cholesterol. Clin Chem 43:1048-1055
16. Laurell S (1966) A method for routine determination of plasma triglycerides. Scand J Clin Lab Invest 18:668-672
17. Prentice RL, Kalbfleisch JD, Peterson AV et al (1978) The analysis of failure times in the presence of competing risks. Biom J 34:541-554 (Pubitemid 9067879)
18. Becker BF (1993) Towards the physiological function of uric acid. Free Radic Biol Med 14:615-631
19. Linder N, Martelin E, Lundin M et al (2009) Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells. Eur J Cancer 45:648-655
20. Kim AW, Batus M, Myint R et al (2011) Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer. Lung Cancer 71:186-190
21. Dziaman T, Banaszkiewicz Z, Roszkowski K et al (2013) 8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients. Int J Cancer 10:1002
22. Schlotte V, Sevanian A, Hochstein P et al (1998) Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro. Free Radic Biol Med 25:839-847 (Pubitemid 28512537)
23. Mika D, Ahmad S, Guruvayoorappan C (2012) Tumour lysis syndrome: implications for cancer therapy. Asian Pac J Cancer Prev 13:3555-3560
24. Edlinger M, Nagel G, Hilbe W et al (2011) Associations of serum uric acid and gamma-glutamyltransferase with cancer in the Vorarlberg health monitoring and promotion programme (VHM&PP) - a short review. Mag Eur Med Oncol 4:50-54
25. Strasak AM, Lang S, Kneib T et al (2009) VHM&PP study group. Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men. Ann Epidemiol 19:15-24
26. Rho YH, Zhu Y, Choi HK (2011) The epidemiology of uric acid and fructose. Semin Nephrol 31:410-419
27. Alvarez-Lario B, Macarron-Vicente J (2011) Is there anything good in uric acid? QJM 104:1015-1024
28. Figarska SM, Boezen HM, Vonk JM (2012) Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/ Vlaardingen study. Eur J Epidemiol 27:867-876